The 1993 NIH Revitalization Act sought to encourage more diverse federally funded clinical studies. But, a team of researchers from the University of California, San Francisco and elsewhere reports in PLOS Medicine this week that less than 2 percent of the more than 10,000 National Cancer Institute-funded clinical trials met the goals for the inclusion of minorities.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.